Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Trimethylsilyldiazomethane

Trimethylsilyldiazomethane

Trimethylsilyldiazomethane structure

Trimethylsilyldiazomethane 

structure
  • CAS No:

    18107-18-1

  • Formula:

    C4H10N2Si

  • Chemical Name:

    Trimethylsilyldiazomethane

  • Synonyms:

    Silane,(diazomethyl)trimethyl-;(Diazomethyl)trimethylsilane;Trimethylsilyldiazomethane;Diazo((trimethylsilyl))methane;Methanediazonium,(trimethylsilyl)-,inner salt;167705-95-5;933674-70-5;1092350-00-9;1620957-06-3

  • Categories:

    Chemical Reagents  >  Organic Reagents

Description

clear yellow solution

Trimethylsilyldiazomethane Basic Attributes

114.22

114.061325

1902903

QI98HQO8C4

DTXSID8074653

Greenish-yellow liquid

29270000

Characteristics

2

0.17

White Solution

0.675 g/cm3

96 °C

−31 °F

1.4362

Immiscible with water. Miscible with organic solvents.

Refrigerator

1.19X10-5 mm Hg at 25 deg C (est)

Henry's Law constant = 0.101 atm-cu m/mole at 25 °C (est)

Liquid; 0.773 g/cu cm at 25 °C /2.0 molar solution in diethyl ether/|Yellow liquid /solution of Trimethylsilyldiazomethane in hexanes/|Stable in neat or in hydrocarbon solution but is decomposed quickly when in carbon tetrachloride and exposed to light. It is not hydrolyzed by neutral water or by 20% potassium hydroxide solution. It can undergo a number of reactions such as with carboxylic acids, cyclohexene, and activated olefins.|Hydroxyl radical reaction rate constant = 2.58X10-12 cu cm/molecule-sec at 25 °C (est)

Safety Information

II

3

UN 1208 3/PG 2

3

12-19-22-66-67-65-62-51/53-48/20-38-11-23-39/26-26-45

9-16-29-33-36/37-61-62-45-28-53

F+,Xn,N,F,T,T+

Stable under recommended storage conditions.. /(Trimethylssilyl)diazomethane solution in n-Hexane/

P201-P210-P280-P308 + P311-P370 + P378-P403 + P235

H225-H302-H330-H336-H350-H370

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal and plant life; and conformance with environmental and public health regulations.|Burn in a chemical incinerator equipped with an afterburner and scrubber but exert extra care in igniting as this material is highly flammable. Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste disposal service to dispose of this material. Dispose of as unused product. /(Trimethylsilyl)diazomethane solution in diethyl ether/|Burn in a chemical incinerator equipped with an afterburner and scrubber but exert extra care in igniting as this material is highly flammable. Observe all federal, state, and local environmental regulations. Contact a licensed professional waste disposal service to dispose of this material. Dispose of as unused product. /(Trimethylssilyl)diazomethane solution in n-Hexane/

Vapors may form explosive mixture with air. /Avoid/ heat, flames and sparks; extremes of temperature and direct sunlight. /(Trimethylsilyl)diazomethane solution in diethyl ether/|Vapors may form explosive mixture with air. /Avoid/ heat, flames and sparks /and/ oxidizing agents. /(Trimethylssilyl)diazomethane solution in n-Hexane/.

|Danger|H225 (11.63%): Highly Flammable liquid and vapor [Danger Flammable liquids]|P201, P202, P210, P233, P240, P241, P242, P243, P260, P261, P264, P270, P271, P273, P280, P281, P284, P302+P352, P303+P361+P353, P304+P340, P307+P311, P308+P313, P310, P311, P314, P320, P321, P332+P313, P362, P370+P378, P391, P403+P233, P403+P235, P405, and P501|Aggregated GHS information provided by 43 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. /Use/ face shield and safety glasses /for eye protection/. Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). /For/ skin and body protection /use/ complete suit protecting against chemicals /and/ flame retardant antistatic protective clothing. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the product. /(Trimethylsilyl)diazomethane solution in diethyl ether/|Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. /Use/ face shield and safety glasses. Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).Choose body protection according to the amount and concentration of the dangerous substance at the work place. Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the product. /(Trimethylssilyl)diazomethane solution in n-Hexane/

Flammable in the presence of a source of ignition when the temperature is above the flash point. Keep away from heat/sparks/open flame/hot surface. No smoking. Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Wear self contained breathing apparatus for fire fighting if necessary. Use water spray to cool unopened containers. /(Trimethylsilyl)diazomethane solution in diethyl ether/|For small (incipient) fires, use media such as "alcohol" foam, dry chemical, or carbon dioxide. For large fires, apply water from as far as possible. Use very large quantities (flooding) of water applied as a mist or spray; solid streams of water may be ineffective. Cool all affected containers with flooding quantities of water. Wear self contained breathing apparatus for fire fighting if necessary. Use water spray to cool unopened containers. /(Trimethylssilyl)diazomethane solution in n-Hexane/

Wear respiratory protection. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapors accumulating to form explosive concentrations. Vapors can accumulate in low areas. Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. Contain spillage, and then collect with an electrically protected vacuum cleaner or by wet-brushing and place in container for disposal according to local regulations. /(Trimethylsilyl)diazomethane solution in diethyl ether/|Wear respiratory protection. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapors accumulating to form explosive concentrations. Vapors can accumulate in low areas. Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. Contain spillage, soak up with non-combustible absorbent material, (e.g. sand, earth, diatomaceous earth, vermiculite) and transfer to a container for disposal according to local / national regulations./(Trimethylssilyl)diazomethane solution in n-Hexane/

Handle products containing trimethylsilyl diazomethane only in a closed system or effectively ventilated laboratory hood. Avoid contact with skin and eyes. Avoid inhalation of vapor or mist. Use explosion-proof equipment. Keep away from sources of ignition - No smoking. Take measures to prevent the build up of electrostatic charge. /(Trimethylsilyl)diazomethane solution in diethyl ether/|Handle products containing trimethylsilyl diazomethane only in a closed system or effectively ventilated laboratory hood. Avoid contact with skin and eyes. Avoid inhalation of vapor or mist. Keep away from sources of ignition - No smoking. Take measures to prevent the build up of electrostatic charge. /(Trimethylssilyl)diazomethane solution in n-Hexane/

Toxicity

Trimethylsilyldiazomethane's production and use as a reagent in organic synthesis(1) for the esterification of carboxylic acids, etherifcation of sterically hindered alcohols and as an alternative to diazomethane(2) may result in its release to the environment through various waste streams(SRC).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), trimethylsilyldiazomethane, which has an estimated vapor pressure of 1.19X10-5 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase trimethylsilyldiazomethane may undergo a hydrolysis reaction with atmospheric water vapor but may also be degraded by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 6 days(SRC), calculated from its rate constant of 2.58X10-12 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3) Particulate-phase trimethylsilyldiazomethane may be removed from the air by wet or dry deposition(SRC). Trimethylsilyldiazomethane does not contain chromophores that absorb at wavelengths >290 nm(4), and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).

The rate constant for the vapor-phase reaction of trimethylsilyldiazomethane with photochemically-produced hydroxyl radicals has been estimated as 2.58X10-12 cu cm/molecule-sec at 25 °C(SRC) using a structure estimation method(1). This corresponds to an atmospheric half-life of about 6 days at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1). Trimethylsilyldiazomethane reacts rapidly with water, and therefore hydrolysis is not expected. Trimethylsilyldiazomethane does not contain chromophores that absorb at wavelengths >290 nm(2), and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).

Bioconcentration is not an important fate since trimethylsilyldiazomethane reacts rapidly with water. (SRC)

Adsorption to soil is not an important fate since trimethylsilyldiazomethane reacts rapidly with water. (SRC)

Volitalization from water/soil is not an important fate since trimethylsilyldiazomethane reacts rapidly with water. (SRC)

Occupational exposure to trimethylsilyldiazomethane may occur through inhalation of solvent vapors in which trimethylsilyldiazomethane is dissolved during organic syntheses. Dermal contact with solutions of this compound in organic solvents may also occur at workplaces where trimethylsilyldiazomethane is produced or used. The general population is not likely to be exposed to trimethylsilyldiazomethane since it is primarily used in a laboratory setting. (SRC)

Drug Information

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/|/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/|/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/

/CASE REPORTS/ A 46 year-old male pharmaceutical chemist presented to the emergency department (ED) with progressive dyspnea. At noon on the prior day, as part of a chemical analysis, he had mixed 2 mL of acetone with 25 mL of L-Malic acid to which was added trimethylsilyldiazomethane (TSDM) dissolved in n-hexane. After 1 hour this mix was combined with an inert gas and a small amount of methylene chloride under a fume hood that was later reported to be nonfunctioning. Although he experienced no immediate mucous membrane irritation, 8 hours post-exposure he developed cough, pleuritic chest pain, hemoptysis, and progressive shortness of breath; by 15 hours, he presented to the ED in respiratory distress, hypoxic (PaO2 67), hypercarbic (PaCO2 46), and acidemic (pH 7.26). A chest radiograph showed an acute lung injury pattern. By 23 hours he required intubation. At 26 hours postexposure he developed profound bradycardia, refractory hypotension, and asystole. Diazomethane (DM) inhalation is known to cause fatal pulmonary edema without an immediate irritant prodrome and with a similar time course to this case. Structural modification of DM with an added trimethylsilyl group makes TSDM less explosive, but its propensity for lung injury is unclear. The chemical admixture as described in this case may have liberated nitrogen gas, but this should not have led to pulmonary injury; nitrogen dioxide should not have evolved. The toxicity may stem from residual DM present in the reagent or a direct effect of TSDM, its metabolites or breakdown products, or potential intracellular formaldehyde formation. The temporal relationship to exposure with inadequate ventilation and clinical effects similar to the analogue toxicant DM support a causal relationship between TSDM and acute lung injury.

TMSCHN2

Trimethylsilyldiazomethane Use and Manufacturing

Methods of Manufacturing

... TMSD /can/ be prepared from either ethyl N-nitroso-N-(trimethylsilylmethyl)urethane or N-nitroso-N-(trimethylsilylmethyl)urea, with the latter giving better product yield. Using the urea compound, addition of potassium hydroxide yields the desired product with hexamethyldisiloxane as a side product; typical preparations reportedly contain 61% and 17% of each, respectively. The reaction can occur at room temperature or below and in various organic solvents (e.g., benzene, decalin, and carbon tetrachloride) or neat. ... /In a similar method/ chloromethyltrimethylsilane /is treated/ with potassium cyanate followed by ammonia to produce the urea compound. The resulting urea was then treated using the method described above to produce TMSD.|... Chloromethyltrimethylsilane is reacted with magnesium to produce trimethylsilylmethylmagnesium chloride. This compound is then reacted with diphenyl phosphorazidate and cold water to yield TMSD.|Prepared by the diazo-transfer reaction of /trimethylsilylmethylmagnesium chloride/ with diphenyl phosphorazidate|Prepared from chloromethyltrimethylsilane using magnesium turnings in diethyl ether to form the corresponding Grignard reagent, trimethylsilylmethylmagnesium chloride. To form trimethylsilyldiazomethane the Grignard reagent is added slowly at low temp to a solution of diphenyl phosphorazidate.

Uses

Reactant for preparation of:&bull Macrolactam analogs of the natural product macrolide (-)-A26771B with improved metabolic stability and antibacterial activity&bull Aigialomycin D analogues as protein kinase inhibitors for cancer treatment&bull Unnatural α-amino acid derivatives containing gem-bisphosphonates via Michael addition reaction&bull Capped 4-methylumbelliferyl hyaluronan disaccharides and tetrasaccharides as potential hyaluronidase substrates&bull Stictamides A-C as matrix metallopeptidase 12 (MMP12) inhibitors with antitumor invasion activity&bull Endothelin converting enzyme (ECE) Inhibitors WS 75624A and WS 75624B via a cross-metathesis approach&bull Ent-kaurene derivatives as anti-inflammatory agents&bull Desmosdumotin C analogs as potent antitumor agents acting via activation of spindle assembly checkpoint&bull Imidazolo[2,1-b]benzothiazole derivatives as potential p53 inhibitors

Sold as a solution in hexanes or diethyl ether (2.0 molar)

TMSD can be isolated by gas chromatography or gas-liquid chromatography.

Computed Properties

Molecular Weight:114.22
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:1
Exact Mass:114.061324862
Monoisotopic Mass:114.061324862
Topological Polar Surface Area:2
Heavy Atom Count:7
Complexity:96.7
Undefined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Trimethylsilyldiazomethane

Latest News on Trimethylsilyldiazomethane

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.